Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.
作者信息
Di Costanzo Giovan Giuseppe
出版信息
Hepatology. 2003 Oct;38(4):1061; author reply 1061. doi: 10.1053/jhep.2003.50391.
PMID:14512897
Abstract
摘要
相似文献
1
Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.肝硬化患者肝细胞癌危险因素的前瞻性分析。
Hepatology. 2003 Oct;38(4):1061; author reply 1061. doi: 10.1053/jhep.2003.50391.
2
[Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
Nihon Naika Gakkai Zasshi. 1995 Dec 10;84(12):1985-91.
3
[Is follow up of hepatocellular carcinoma in patients with liver cirrhosis justified?].[对肝硬化患者的肝细胞癌进行随访是否合理？]
Gastroenterol Clin Biol. 1992;16(11):910.
4
Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.慢性肝病患者肝细胞癌的危险因素
N Engl J Med. 1993 Dec 16;329(25):1897; author reply 1897-8.
5
Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.慢性肝病患者肝细胞癌的危险因素。
N Engl J Med. 1993 Dec 16;329(25):1896-7; author reply 1897-8. doi: 10.1056/NEJM199312163292518.
6
[Screening for hepatocellular carcinoma in cirrhotic patients].[肝硬化患者肝细胞癌的筛查]
Gastroenterol Clin Biol. 2000 May;24(5 Pt 2):B92-4.
7
Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.肿瘤因素对晚期肝硬化（Child-Pugh C级）和肝细胞癌患者预后的影响
J Gastroenterol Hepatol. 2005 Jun;20(6):963-5. doi: 10.1111/j.1440-1746.2005.03841.x.
8
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析：一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.
9
Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.丙型肝炎病毒相关性肝硬化患者肝细胞癌的危险因素：我们所了解的与缺失的内容。
J Hepatol. 2006 Jun;44(6):1013-6. doi: 10.1016/j.jhep.2006.04.001.
10
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.熊去氧胆酸的使用可能与丙型肝炎病毒相关性肝硬化患者肝细胞癌发病率较低有关。
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):164-9.
引用本文的文献
1
Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.表皮生长因子61A/G基因多态性对肝细胞癌风险影响的定量评估。
Oncol Lett. 2015 Nov;10(5):3199-3205. doi: 10.3892/ol.2015.3723. Epub 2015 Sep 18.
Zotero 插件